Sv Life Sciences Advisers Cut Ocular Therapeutix (OCUL) Holding, Deutsche Bank Ag Cut Honda Motor LTD (HMC) Position By $696,551

June 19, 2017 - By Louis Casey

Deutsche Bank Ag decreased Honda Motor Ltd (HMC) stake by 3.9% reported in 2016Q4 SEC filing. Deutsche Bank Ag sold 24,019 shares as Honda Motor Ltd (HMC)’s stock declined 12.43%. The Deutsche Bank Ag holds 591,685 shares with $17.27M value, down from 615,704 last quarter. Honda Motor Ltd now has $50.02B valuation. The stock declined 0.36% or $0.1 reaching $27.76 per share. About 160,191 shares traded. Honda Motor Co Ltd (ADR) (NYSE:HMC) has risen 4.10% since June 19, 2016 and is uptrending. It has underperformed by 12.60% the S&P500.

Sv Life Sciences Advisers Llc decreased Ocular Therapeutix Inc (OCUL) stake by 16.94% reported in 2016Q4 SEC filing. Sv Life Sciences Advisers Llc sold 327,400 shares as Ocular Therapeutix Inc (OCUL)’s stock rose 2.57%. The Sv Life Sciences Advisers Llc holds 1.61 million shares with $13.44 million value, down from 1.93 million last quarter. Ocular Therapeutix Inc now has $302.47M valuation. The stock rose 3.77% or $0.38 reaching $10.54. About 104,731 shares traded. Ocular Therapeutix Inc (NASDAQ:OCUL) has declined 9.50% since June 19, 2016 and is downtrending. It has underperformed by 26.20% the S&P500.

Analysts await Honda Motor Co Ltd (ADR) (NYSE:HMC) to report earnings on August, 1. They expect $0.87 EPS, down 7.45% or $0.07 from last year’s $0.94 per share. HMC’s profit will be $1.57 billion for 7.98 P/E if the $0.87 EPS becomes a reality. After $0.47 actual EPS reported by Honda Motor Co Ltd (ADR) for the previous quarter, Wall Street now forecasts 85.11% EPS growth.

Deutsche Bank Ag increased Juniper Networks Inc (NYSE:JNPR) stake by 283,399 shares to 2.24M valued at $63.31 million in 2016Q4. It also upped Broadcom Ltd stake by 1.85 million shares and now owns 1.86M shares. Simpson Manufacturing Co Inc (NYSE:SSD) was raised too.

Among 9 analysts covering Honda Motor Co (NYSE:HMC), 2 have Buy rating, 5 Sell and 2 Hold. Therefore 22% are positive. Honda Motor Co had 14 analyst reports since August 27, 2015 according to SRatingsIntel. The stock has “Buy” rating by Jefferies on Friday, May 13. The firm earned “Buy” rating on Friday, February 26 by Jefferies. Erste Group downgraded the shares of HMC in report on Monday, April 25 to “Sell” rating. The rating was downgraded by Macquarie Research to “Neutral” on Thursday, December 1. On Saturday, February 4 the stock rating was upgraded by Macquarie Research to “Outperform”. The company was downgraded on Friday, October 9 by Jefferies. Jefferies maintained it with “Buy” rating and $35 target in Monday, May 29 report. The company was initiated on Tuesday, December 22 by Susquehanna. The company was downgraded on Friday, May 27 by UBS. The firm earned “Underperform” rating on Friday, May 13 by Credit Agricole.

Among 5 analysts covering Ocular Therapeutix (NASDAQ:OCUL), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Ocular Therapeutix had 9 analyst reports since August 5, 2015 according to SRatingsIntel. The rating was upgraded by Morgan Stanley on Thursday, February 18 to “Overweight”. The rating was downgraded by Morgan Stanley to “Equal-Weight” on Friday, October 23. The firm has “Equal Weight” rating given on Thursday, August 13 by Morgan Stanley. The stock of Ocular Therapeutix Inc (NASDAQ:OCUL) has “Outperform” rating given on Tuesday, November 15 by RBC Capital Markets. As per Thursday, April 28, the company rating was maintained by Morgan Stanley. Morgan Stanley maintained the stock with “Overweight” rating in Tuesday, June 7 report. The company was initiated on Wednesday, August 5 by Nomura. On Thursday, August 11 the stock rating was initiated by JMP Securities with “Outperform”. Cantor Fitzgerald initiated the stock with “Overweight” rating in Friday, February 10 report.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: